A smart spacer to help children with uncontrolled asthma use their inhalers
Tests a smart spacer for inhaler technique in children with uncontrolled asthma.
Plain-language title generated from the registry record
Registry title: Using a Digital Spacer for Inhaler Technique Education in Pediatric Asthma
Key facts
- Where
- Groningen, NetherlandsSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers aged 6 to 18 with asthma that is not well controlled. They use a pMDI inhaler with a spacer.
- Age
- 6 to 18 years
- Sex
- Boys and girls
- Disease stage
- Asthma diagnosed by a doctor that is not well controlled (ACT <19 and/or a recent asthma attack and/or suspected missed doses or poor inhaler technique).
- Earlier treatment
- Must use ICS ± LABA ± LAMA ± SABA with a pMDI and a spacer that suits the aflo™ device.
Main reasons for not taking part
- Chronic lung disease other than asthma
- Significant heart disease
- Cannot understand Dutch well enough
- No access to stable mobile internet
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 18 years old?
Source: NCT07803042, who can take part
Where in Netherlands
- UMC GroningenGroningen, NetherlandsNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Groningen
- Trial code
- NCT07803042
- Record updated
- 3 September 2026
- Original description
This pilot study evaluates the feasibility, usability, and potential effect of the aflo™ Smart Spacer platform in children aged 6-18 with uncontrolled asthma using pMDIs and spacers. The study investigates changes in inhaler technique, asthma control, and lung function following 3 months of daily use of the CE-marked aflo™ device.Read full original descriptionShow less
Using the Aflo™ Digital Smart Spacer Platform to Improve Inhaler Technique in Children With Uncontrolled Asthma: A Prospective Pilot Study - INSPIRE-KIDS (INhaler SPacer Improvement & Real-time Education - KIDS)
This pilot study evaluates the feasibility, usability, and potential effect of the aflo™ Smart Spacer platform in children aged 6-18 with uncontrolled asthma using pMDIs and spacers. The study investigates changes in inhaler technique, asthma control, and lung function following 3 months of daily use of the CE-marked aflo™ device.
Inclusion: Age 6-18 years; Physician-diagnosed asthma; Using ICS ± LABA ± LAMA ± SABA via pMDI and spacer suitable for aflo™; Uncontrolled asthma (ACT <19 and/or recent exacerbation and/or suspected nonadherence/poor technique); Access to an Apple or Android smartphone (OS ≥ 4.3); Willing and able to give assent/consent (parents/guardians for minors).
Exclusion: Chronic lung disease other than asthma; Significant cardiac disease; Not able to understand Dutch sufficiently; No access to stable mobile internet.